Generation of an induced pluripotent stem cell line (SYSUi005-A) from a patient with hypertrophic cardiomyopathy

Stem Cell Research - Tập 58 - Trang 102626 - 2022
Chi Zhang1, Jian Shi2, Zhen Zhang1, Qianqian Zhao1, Manting Xie1, Ying Chen3, Qiuling Xiang1
1Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China
2Department of Cardiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China
3Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Tài liệu tham khảo

Gersh, 2011, ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol., 58, E212, 10.1016/j.jacc.2011.06.011 Marston, 2012, How do MYBPC3 mutations cause hypertrophic cardiomyopathy?, J. Muscle Res. Cell Motility, 33, 75, 10.1007/s10974-011-9268-3 Seki, 2010, Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells, Cell Stem Cell, 7, 11, 10.1016/j.stem.2010.06.003
Thông tin
Thông tin xuất bản

Stem Cell Research

Tập 58

102626

Thông tin tác giả